Products & Tech | Page 57 of 63

Novo Nordisk Re-Initiates Phase 3 Development of Liraglutide (Victoza) for Obesity Treatment

Novo Nordisk today announced the decision to re-initiate the global phase 3 development program of liraglutide for the treatment of obesity. Following the US approval of Victoza for the treatment of type 2 diabetes, Novo Nordisk has been in dialogue with the FDA regarding the further progression of the development program investigating...

Depomed Recalls Type 2 Diabetes Drug Glumetza

Drug developer Depomed Inc announced it would recall 52 lots of its type 2 diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle, according to a Reuters report...

New Type 2 Diabetes Drug Bydureon Shows Better Results Than Januvia

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. announced results from DURATION-4, the fourth in a series of studies designed to test the superiority of Bydureon (exenatide extended-release for injectable suspension), an investigational type 2 diabetes therapy, as compared to other type 2 diabetes medications...

Lindsey’s Guide to Surviving College with the Big D, The Schedules and Connections Edition

If you can get a schedule that works with your insulin regimen, you’ve been blessed. So try for that...

Oral Insulin AFREZZA Successful at Controlling Blood Sugar Levels in Type 1 Diabetes Patients

MannKind announced that results of a new 16-week trial show that the investigational ultra rapid acting mealtime insulin, AFREZZA (insulin human [rDNA origin]) Inhalation Powder, combined with basal insulin, is clearly non-inferior to standard therapy insulin lispro, a rapid acting insulin (also combined with basal insulin), in reducing HbA1c levels in subjects with inadequately controlled type 1 diabetes...

Medtronic to Release New iPro 2 CGM Monitor

Medtronic, Inc. announced the launch of iPro 2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications. ..

Type 2 Diabetes May Be Prevented With a Combination of Avandia and Metformin

According to a new report published in the Lancet, taking a low dose of GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) combined with metformin was highly effective in prevention of type 2 diabetes in patients with impaired glucose tolerance, with little effect on the clinically relevant adverse events of these two drugs. The study included 207 patients with impaired glucose...

Novo Nordisk to Launch Victoza in Japan

Novo Nordisk announced that it has received approval for the price of Victoza, a once-daily human GLP-1 analogue for the treatment of type 2 diabetes, from Japan’s Central Social Insurance Medical Council (Chuikyo), the advisory committee to the Minister of Health, Labour and Welfare. The price approval allows Novo Nordisk to commercially launch in Japan shortly after Victoza is officially posted on Japan’s National Health Insurance price list on June 11th...

GlaxoSmithKline Settles More Avandia Lawsuits

GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine. According to a Reuters report, a spokeswoman for Glaxo said that consolidated cases which had been due to come to court...

Novo Nordisk to Stop Insulin Sales in Greece

Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices...